Literature DB >> 24357164

A novel post-ligation thioesterification device enables peptide ligation in the N to C direction: synthetic study of human glycodelin.

Takaomi Takenouchi1, Hidekazu Katayama, Yuko Nakahara, Yoshiaki Nakahara, Hironobu Hojo.   

Abstract

Human glycodelin consists of 162 amino acid residues and two N-linked glycans at Asn(28) and Asn(63) . In this study, we synthesized it by a fully convergent strategy using native chemical ligation (NCL) in N to C direction. The four peptide segments corresponding to 1-31, 32-65, 66-105 and 106-162 sequences were synthesized by 9-fluorenylmethoxycarbonyl based solid-phase peptide synthesis. At the C-terminus of the second segment, N-ethyl-S-acetamidomethyl-cysteine was attached as a post-ligation thioesterification device. The N-terminal two segments were condensed by the homocysteine-mediated NCL at Leu-Met site, and the product was methylated to convert homocysteine to methionine. After deprotection of acetamidomethyl group on the N-ethylcysteine residue, the peptide was thioesterified by N-alkylcysteine-assisted method. The product was then ligated with the C-terminal half, which was obtained by the NCL of third and fourth segments, to give the full-length glycodelin.
Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Keywords:  N-alkylcysteine; glycodelin; native chemical ligation; peptide thioester; thioesterification

Mesh:

Substances:

Year:  2013        PMID: 24357164     DOI: 10.1002/psc.2592

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  2 in total

1.  Removal of the 5-nitro-2-pyridine-sulfenyl protecting group from selenocysteine and cysteine by ascorbolysis.

Authors:  Emma J Ste Marie; Erik L Ruggles; Robert J Hondal
Journal:  J Pept Sci       Date:  2016-08-02       Impact factor: 1.905

2.  A new method of N to C sequential ligation using thioacid capture ligation and native chemical ligation.

Authors:  Wen Hou; Lei Liu; Xiaohong Zhang; Chuanfa Liu
Journal:  R Soc Open Sci       Date:  2018-06-20       Impact factor: 2.963

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.